Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction (Version 3: Revised May 20th, 2024)
Joint Committee of NSF and Use of Gadolinium-Based Contrast Agents (Japan Radiological Society, Japanese Society of Nephrology)
Springer Nature ·
2025-01-03
· DOI 10.1007/s10157-024-02607-2
The publisher did not provide an abstract — full text is available via the link below.
Joint Committee of NSF and Use of Gadolinium-Based Contrast Agents (Japan Radiological Society, Japanese Society of Nephrology). Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction (Version 3: Revised May 20th, 2024). // Clinical and Experimental Nephrology. – 2025. – DOI: 10.1007/s10157-024-02607-2. – URL: https://doi.org/10.1007/s10157-024-02607-2
Joint Committee of NSF and Use of Gadolinium-Based Contrast Agents (Japan Radiological Society & Japanese Society of Nephrology) (2025). Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction (Version 3: Revised May 20th, 2024). Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-024-02607-2
Joint Committee of NSF and Use of Gadolinium-Based Contrast Agents (Japan Radiological Society and Japanese Society of Nephrology). “Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction (Version 3: Revised May 20th, 2024).” Clinical and Experimental Nephrology, 2025. doi:10.1007/s10157-024-02607-2.
@article{Society2025,
title = {Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction (Version 3: Revised May 20th, 2024)},
author = {Society, Joint Committee of NSF and Use of Gadolinium-Based Contrast Agents (Japan Radiological and Nephrology), Japanese Society of},
journal = {Clinical and Experimental Nephrology},
year = {2025},
doi = {10.1007/s10157-024-02607-2},
url = {https://doi.org/10.1007/s10157-024-02607-2}
}